Kaynakça
Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med. 1999;340:839-46.
Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg. 1999;68:75-8.
Oliver JM, Gallego P, González A, Benito F, Mesa JM, Sobrino JA. Predisposing conditions for atrial fibrillation in atrial septal defect with and without operative closure. Am J Cardiol. 2002;89:39-43.
Giardini A, Donti A, Sciarra F, Bronzetti G, Mariucci E, Picchio FM. Long-term incidence of atrial fibrillation and flutter after transcatheter atrial septal defect closure in adults. Int J Cardiol. 2009;134:47-51.
Spies C, Khandelwal A, Timmermanns I, Schräder R. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults. Am J Cardiol. 2008;102:902-6.
Abaci A, Unlu S, Alsancak Y, Kaya U, Sezenoz B. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies. Catheter Cardiovasc Interv. 2013;82:1123-38.
Morton JB, Sanders P, Vohra JK, et al. Effect of chronic right atrial stretch on atrial electrical remodeling in patients with an atrial septal defect. Circulation. 2003;107:1775-82.
Fang F, Luo XX, Lin QS, et al. Characterization of mid-term atrial geometrical and electrical remodeling following device closure of atrial septal defects in adults. Int J Cardiol. 2013;168:467-71.
Chubb H, Whitaker J, Williams SE, et al. Pathophysiology and management of arrhythmias associated with atrial septal defect and patent foramen ovale. Arrhythm Electrophysiol Rev. 2014;3:168-72.
Goette A, Corradi D, Dobrev D, et al. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. 2024;26:euae204.
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021;42:563-645.
Johnson JN, Marquardt ML, Ackerman MJ, et al. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure. Catheter Cardiovasc Interv. 2011;78:254-61.
Dilaveris PE, Gialafos JE. P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol. 2001;6:159-65.
Aytemir K, Ozer N, Atalar E, et al. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000;23:1109-12.
Ozer N, Aytemir K, Atalar E, et al. P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000;23:1859-62.
Okutucu S, Aytemir K, Oto A. P-wave dispersion: What we know till now? JRSM Cardiovasc Dis. 2016;5:2048004016639443.
Magnani JW, Williamson MA, Ellinor PT, Monahan KM, Benjamin EJ. P wave indices: current status and future directions in epidemiology, clinical, and research applications. Circ Arrhythm Electrophysiol. 2009;2:72-9.
Chen LY, Ribeiro ALP, Platonov PG, et al. P wave parameters and indices: a critical appraisal of clinical utility, challenges, and future research-a consensus document endorsed by the International Society of Electrocardiology and the International Society for Holter and Noninvasive Electrocardiology. Circ Arrhythm Electrophysiol. 2022;15:e010435.
Bethell HJ, Nixon PG. P wave of electrocardiogram in early ischaemic heart disease. Br Heart J. 1972;34:1170-5.
Wolder LD, Graff C, Baadsgaard KH, et al. Electrocardiographic P terminal force in lead V1, its components, and the association with stroke and atrial fibrillation or flutter. Heart Rhythm. 2023;20:354-62.
Eranti A, Aro AL, Kerola T, et al. Prevalence and prognostic significance of abnormal P terminal force in lead V1 of the ECG in the general population. Circ Arrhythm Electrophysiol. 2014;7:1116-21.
Woo SB, Jang SI, Kim SH, et al. Transcatheter closure of secundum atrial septal defect in patients over 60 years old. Korean Circ J. 2013;43:110-4.
Wagdi P. Incidence and predictors of atrial fibrillation following transcatheter closure of interatrial septal communications using contemporary devices. Clin Res Cardiol. 2010;99:507-10.
Bronzetti G, D’Angelo C, Donti A, et al. Role of atrial fibrillation after transcatheter closure of patent foramen ovale in patients with or without cryptogenic stroke. Int J Cardiol. 2011;146:17-21.
Berger F, Vogel M, Kretschmar O, Dave H, Prêtre R, Dodge-Khatami A. Arrhythmias in patients with surgically treated atrial septal defects. Swiss Med Wkly. 2005;135:175-8.
Deaconu S, Deaconu A, Marascu G, et al. Arrhythmic risk and treatment after transcatheter atrial septal defect closure. Diagnostics (Basel). 2023;14:33.
Doğduş M, Turan OE, Başkurt AA, et al. An effective novel index for predicting the recurrence of atrial fibrillation ablation: p wave duration-to-amplitude ratio. Turk Kardiyol Dern Ars. 2022;50:498-504.
Antoun I, Li X, Vali Z, et al. The value of P-wave parameters changes in predicting catheter ablation outcomes for paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol. 2025;30:e70047.
Masood S, Ashraf SMK, Malik MA, Wahab S. P-wave indices and left atrial mechanics as predictors of atrial cardiopathy in embolic stroke of undetermined source. Sci Rep. 2023;13:19965.
Intzes S, Zagoridis K, Symeonidou M, et al. P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis. Europace. 2023;25:450-9.
Maezono A, Oishi E, Sasaki T, et al. Electrocardiographic P-wave indices and onset of atrial fibrillation and histological fibrosis in a general Japanese population: a prospective cohort analysis of the Hisayama Study. Eur Heart J Open. 2025;5:oeaf126.
Arslan GY, Söner S. P-wave terminal force in lead V1-Morris index after catheter ablation: a study in atrial fibrillation and typical atrial flutter patients. Eskisehir Med J. 2026;7:134-7.
Sudo Y, Morimoto T, Tsushima R, et al. P-wave terminal force in lead V1 and outcomes in patients with persistent atrial fibrillation undergoing catheter ablation. Am Heart J. 2023;141-150.
Wang Z, Wang B, Yang Y, Yang X, Che Y, Xia Y. P-wave terminal force in lead V1 is associated with recurrence after catheter ablation in patients with paroxysmal atrial fibrillation and normal left atrial size. Front Cardiovasc Med. 2024;11:1467585.
Tereshchenko LG. P-terminal force in lead V1: May the force be with you. Heart Rhythm. 2023;20:363-4.
